Are you traveling to St. Martin's? I have a new I.V. ozone patient who has a timeshare in St. Martin's and goes every year. It's beautiful, but you'll never guess what she picked up on the island . . . .
Dengue fever from a mosquito bite. Unbelievable and more unbelievable because I have specialized oral medicine for it. We are doing a two-pronged approach with oral medications and I.V. ozone therapy to combat the virus which really knocked her out. She is recovering with I.V. Ozone and ozone inhalation therapy.
Another mosquito-borne Caribbean virus that hit more than 1.24 million cases is Chikungunya virus that causes high fever and debilitating joint pain. It was rare in this part of the world until December 2013 and by the end of February 2015 there were over 1.2 million cases that have affected every country in the hemisphere. Chikungunya usually comes from Africa or Asia where it is endemic.
There is no specific treatment or vaccine, but we have your treatment to erradicate the virus. If you visit the Caribbean wear long sleeves and pants during the day. You can wipe your skin and open areas with a combination of natural essential oils that repel insects. Lavender, Thyme, Oregano, Eucalyptus and even Bitter Orange. These are available at Emerson Ecologics. Visit our virtual pharmacy. Click Restore and click Emerson. Passcode is SECOND. You can buy and ship direct without any hidden cost or multi-level marketing schemes.
Second Nature Care Ozone Therapy - Ozone Therapy Kills Viruses
They are working on a vaccine that is administered on day 1 followed by another shot 4 weeks later and a final shot in week 20, but after watching Bought I wouldn't sign up anytime soon for the vaccine. It has only been tested in 25 volunteers while the control group got the MMR vaccine. The vaccine is a genetically-modified version of a live attenuated virus and most likely has aluminum and formaldehyde in it. Not good for the brain as both cross blood-brain barrier and cause oxidative brain injuries.
90% in the high-dose group showed the presence of neutralizing anti-chikungunya antibodies on day 28. 24 participants had headaches, 50% had injection site pain and 19 had influenza-like illness. 11 had nasopharyngitis and 5 had oropharyngeal pain.
Seven adverse events in 6 participants were severe including 5 linked to the vaccine.
No thanks, I think I'll stick to I.V. Ozone therapy.
